Related Experiment Videos
Trial of droperidol as an antiemetic in cisplatin chemotherapy
Cancer Treatment Reports
|April 1, 1986
Abstract:
A trial of droperidol as an antiemetic was undertaken during 48 courses of cisplatin chemotherapy in 31 patients with cancer. The optimal loading dose was 10 mg iv, with a maintenance dose of 4 mg iv every 2 hours for four additional doses. Beyond this level, cardiovascular side effects became problematic.